About Us

Dr. Salahshor is an Adjunct Professor at the University of Toronto and an experienced expert in life sciences, healthcare, and medical guidelines and policies, with a strong focus on scientific strategy and clinical affairs.

She has led research in oncology, molecular diagnostics, medical genetics, and emerging fields, including psychedelic medicine and health technology.

Dr. Salahshor advises startups and organizations in the MedTech, AI health, and pharmaceutical sectors, supporting commercialization, due diligence, and business development. She designs educational programs, evaluates diagnostic tests, and fosters collaborations across academia, government, and industry.

With global experience and an entrepreneurial mindset, Dr. Salahshor brings strategic insight into innovation, healthcare policy, and scientific advancement.

Key Activity: Medical Genetics, Oncology and Cancer Research, Diagnostics and Prognostics, Start-up Advisory, Private Investment, Medical Imaging Technologies, Biomarkers, HealthTech, and Health AI-related Programs.

Dr. Farahati is an adjunct professor and an experienced Senior Medical Economics Advisor specializing in cost-effectiveness modelling, HEOR evaluations, and payer analytics across the U.S. and Canadian healthcare markets. She supports insurers and healthcare systems with ROI modelling, utilization forecasting, and reimbursement optimization, including Fee-for-Service and value-based care strategies.

With expertise in Medicare, Medicaid, and private payer models, Dr. Farahati advises on pricing strategies, risk adjustment, and claims-based forecasting. She is proficient in SAS, SQL, and Stata, applying over 20 years of experience in healthcare data automation and analytics.

Through data-driven insights, Dr. Farahati helps organizations align financial performance with clinical impact to drive sustainable healthcare value.

Key Activity:  Health Economics and Outcome Research (HEOR)∙ Health Insurance. Real-world evidence (RWE)∙

Medical Claims, Utilization Analytics & Forecasting∙ Stata SAS  SQL Programming.

Dr. Ebrahimzadeh is a neuroscientist with over a decade of research experience in neuropharmacology and CNS drug development. He provides scientific oversight, research strategy, and medical writing expertise for Shiruy’s biotech and pharmaceutical clients. His work has contributed to peer-reviewed publications and regulatory submissions supporting innovative therapeutic programs.

Key Activity: Neuroscience, Neuropharmacology, CNS Drug Development, Pre-clinical Efficacy and Toxicity Studies (FDA IND-enabling), Phase 1 and 2 Clinical Trials, Regulatory Submissions, Health Canada, FDA, Therapeutic Goods Administration (TGA), Data and Statistical Analysis.